BIOPHEN Heparin Anti-Xa (2 stages) - Replaced by A221005
Chromogenic anti-Xa method for measuring homogeneously heparin in plasma (tested diluted 1:10) or in purified systems, using a two stage method. Offers a wide measurement range from 0 to 1 IU/mL for plasma, or from 0.005 to 0.10 IU/mL for purified systems and is appropriate for testing heparins for their anti-FXa activity. This assay is in compliance with USP Anti-FXa assay for unfractionated heparin.Please see important notification letter from the manufacturer regarding the use of this product.
For the measurement of anti-Xa Heparin activity in research applications.
This assay, using a predilution of Antithrombin and FXa reagents in R4 buffer, is in compliance with the USP Anti-Factor Xa assay for unfractionated heparin.
Please Note: Results obtained should be for research purposes only and not used for patient diagnosis or treatment.
Instructions For Use
Material Safety Data Sheet (MSDS)
Certificate of Analysis (COA)